Develop an understanding of the biz, industry, competitive intensity, management, valuation
This thread is to create awareness on how to use
https://t.co/3jeqlXO0QH
Please note that i am not officially associated with website. Only an active contributor & hope to benefit from network effects of interested investors actively contributing on platform.
Develop an understanding of the biz, industry, competitive intensity, management, valuation
These enable investor to level up the most. These discussions are a showcase for the website itself.
These are also a great starting point. Since VP is not a course, feel free to traverse them in any order
https://t.co/ltsVOUeJ9j
It has 2083 posts of this writing written since Sep 2012. Read all of them. Read the links, pdfs, videos embedded in this thread.
but aim to read "hall of fame" & "learning" too in some medium term horizon
you are taken to the full set of threads on everything on the valuepickr forum.
Go to the "about" page and understand the rules and description of what this category is about.
See this thread i started for indigo paints:
https://t.co/QmtSnm6Luv
Posts like "what is happening to the price" are borderline spam. Add posts which add value. Remain mindful & respectful. Focus on doing analysis & adding value.
This category of threads is the ones with least restrictions.
https://t.co/UrEHlvoxQP
Feel free to explore portfolio threads here or ask Qs on common beginner investor doubts thread.
https://t.co/Xw2vc1CU3x
Eg: see this collaborators corner thread on laurus labs:
https://t.co/ofEhhgcbTP
Provide as much info as you can when signing up.
Eg: see my page:
https://t.co/nxgjHM79WG
This is publicly visible to everyone.
one of biggest source of learning for me has been collaborative filtering:
Looking to learn from writings of those ahead of me in investing curve.
PS: this is not an official take on VP. only writing as a user. (I am also a collaborator on VP, but dont benefit from it in any way).
My only intention is to motivate enough people to contribute good data driven analysis on platform.
More from Sahil Sharma
Most of market does not beat the market by a lot. Which is alright.
In any activity the distribution of outcomes follows bell curve (Gaussian).
Those that are willing to put in effort reap the benefits. 😀
Otherwise we always have option to go for hard working PM's/etf/mf
For lot of consumer facing cos scuttlebutt is actually not that hard. We find reviews online (eg: app reviews on playstore, or reviews of products on social media)
B2B is hard to scuttlebutt, need to reach out to people in co and hope that are willing to talk. Connections help
In any activity the distribution of outcomes follows bell curve (Gaussian).
Those that are willing to put in effort reap the benefits. 😀
Otherwise we always have option to go for hard working PM's/etf/mf
Things to need to do before you buy a stock. I wonder though how many investors have the ability for item numbers 5, 6 & 7. I don't pic.twitter.com/E5AMVxbpNb
— Prashanth (@Prashanth_Krish) August 16, 2021
For lot of consumer facing cos scuttlebutt is actually not that hard. We find reviews online (eg: app reviews on playstore, or reviews of products on social media)
B2B is hard to scuttlebutt, need to reach out to people in co and hope that are willing to talk. Connections help
#neulandlab 🌋🌋 read on to understand this company and its story of transformation. On twitter, 🌋 has become synonymous with neuland, and this is how i will use it throughout the thread. If you like the thread, plz retweet & help fellow investors learn
Starting with a simple primer on the Pharma industry. They make medicines for all of us. The part of the medicine which gives it its potency against the ailment it cures is called API: Active Pharmaceutical
(here is a reference few people will get, but have to make it since I love it :D):
If Guardians of the globe (https://t.co/vH2C1TDbPy) were a medicine, Omniman (https://t.co/0DGb1MAtXN) is the API.
Back to 🌋. There are pharma companies which sell APIs as well as the finished medicine (FDF: Finished Dosage Formulation). Neuland are pureplay API manufacturers. This provides them some advantage since they don't compete with their clients (the FDF makers).
Medicine is diverse. There are medicine which were first discovered in 1920s (https://t.co/6DXNrhOK46), to those being created now (https://t.co/tcr7dAexmO). Naturally then, some of this involves very complex chemistry to manufacture, others are relatively easier to manufacture.
Starting with a simple primer on the Pharma industry. They make medicines for all of us. The part of the medicine which gives it its potency against the ailment it cures is called API: Active Pharmaceutical
(here is a reference few people will get, but have to make it since I love it :D):
If Guardians of the globe (https://t.co/vH2C1TDbPy) were a medicine, Omniman (https://t.co/0DGb1MAtXN) is the API.
Back to 🌋. There are pharma companies which sell APIs as well as the finished medicine (FDF: Finished Dosage Formulation). Neuland are pureplay API manufacturers. This provides them some advantage since they don't compete with their clients (the FDF makers).
Medicine is diverse. There are medicine which were first discovered in 1920s (https://t.co/6DXNrhOK46), to those being created now (https://t.co/tcr7dAexmO). Naturally then, some of this involves very complex chemistry to manufacture, others are relatively easier to manufacture.
More from All
You May Also Like
“We don’t negotiate salaries” is a negotiation tactic.
Always. No, your company is not an exception.
A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.
Listen to Aditya
And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.
I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.
You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.
Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]
Always. No, your company is not an exception.
A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.
Listen to Aditya
"we don't negotiate salaries" really means "we'd prefer to negotiate massive signing bonuses and equity grants, but we'll negotiate salary if you REALLY insist" https://t.co/80k7nWAMoK
— Aditya Mukerjee, the Otterrific \U0001f3f3\ufe0f\u200d\U0001f308 (@chimeracoder) December 4, 2018
And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.
I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.
You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.
Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]
